(Q33449734)

26 July 2017

title

Absence of plasma prostacyclin stimulating activity deficiency in hemolytic uremic syndrome (English)

1 reference

26 July 2017

Schlegel N

1 reference

26 July 2017

Maclouf J

1 reference

26 July 2017

Loirat C

1 reference

26 July 2017

Drouet L

1 reference

26 July 2017

Marotte R

1 reference

26 July 2017

Scarabin PY

1 reference

26 July 2017

Mathieu H

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 July 1987

1 reference

The Journal of Pediatrics

26 July 2017

published in

1 reference

26 July 2017

volume

111

1 reference

26 July 2017

1 reference

26 July 2017

page(s)

71-77

1 reference

Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity?

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980344-X

Familial deficiency of prostacyclin production stimulating factor in the hemolytic uremic syndrome of childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980344-X

Accelerated prostacyclin degradation in the thrombotic thrombocytopenic purpura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980344-X

Serum prostacyclin binding defects in thrombotic thrombocytopenic purpura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980344-X

Localisation and stimulation of prostacyclin production in vascular cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980344-X

Stimulation of vascular smooth muscle cell prostacyclin and prostaglandin E2 synthesis by plasma high and low density lipoproteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980344-X

Inhibition of vascular epoprostenol (prostacyclin, PGI2) production in vitro by plasma from healthy subjects and patients with severe renal impairment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980344-X

Inherited plasma factor deficiency in haemolytic-uraemic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980344-X

Familial deficiency of a plasma factor stimulating vascular prostacyclin activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980344-X

Further studies on the enzymatic conversion of prostaglandin endoperoxide into prostacyclin by porcine aorta microsomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980344-X

A radioimmunoassay for 6-keto-PGF1 alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980344-X

Comparison of radioimmunoassay and high-resolution gas chromatography mass spectrometry for the quantitative determination of serum thromboxane B2 and 6-keto-PGF1α after pharmacological blockade of thromboxane synthetase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980344-X

Inhibitor of prostacyclin production in sporadic haemolytic uraemic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980344-X

Prostanoids in hemolytic uremic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980344-X

Platelet and vascular arachidonic acid metabolites: can they help detect a tendency towards thrombosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980344-X

Haemolytic-uraemic syndrome: an analysis of prognostic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980344-X

Hemolytic-uremic syndrome: an analysis of the natural history and prognostic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980344-X

Unbalanced prostaglandin synthesis and plasma factors in uraemic bleeding. A hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980344-X

A plasma factor in uraemia which stimulates prostacyclin release from cultured endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980344-X

Deficiency of plasma prostacyclin or PGI2 regenerating ability in sickle cell anaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980344-X

Plasmapheresis in the haemolytic-uraemic syndrome in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980344-X

Novel platelet-agglutinating protein from a thrombotic thrombocytopenic purpura plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980344-X

Haemolytic uraemic syndrome: therapeutic effect of plasma infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980344-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(87)80344-X

1 reference

26 July 2017

1 reference